Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
13.90
+0.33 (2.43%)
Mar 9, 2026, 1:09 PM EDT - Market open
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $704.35 million as of March 9, 2026. Its market cap has increased by 48.28% in one year.
Market Cap
704.35M
Enterprise Value
399.51M
1-Year Change
48.28%
Ranking
Category
Stock Price
$13.90
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $704.35M, a decrease of -4.91%. That is a compound annual growth rate of -0.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 687.60M | -27.48% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 730.31M |
| Prime Medicine | 710.09M |
| Gyre Therapeutics | 700.76M |
| Jade Biosciences | 692.89M |
| ProKidney | 691.92M |
| Tectonic Therapeutic | 673.52M |
| MiMedx Group | 668.55M |
| Replimune Group | 666.36M |